Learn MoreThe Centre of Applied Neurogenetics has identified a new gene for Parkinson disease providing new clues towards the understanding of the pathological mechanisms of disease and paving the way to novel therapeutic targets.
Learn MoreCentre for Brain Health: University of British Columbia announces a new facility that will integrate clinicians and researchers to aid in making signifigant advances that will benefit patient care and cutting edge scientific discovery for people around the world!
The goal for Centre for Applied Neurogenetics (CAN) is to accelerate drug development for Parkinson disease and other neurologic and neurodegenerative disorders via applied neurogenetics and molecular neuroscience. Learn More
To develop a cure requires patients and families to get involved, the collaboration of expert neurologists, and a scientific team with a passion for molecular neuroscience. There are many ways to get involved!Learn More
News & Events
Learn MoreDr. Matthew Farrer has been appointed the Dr. Donald Rix B.C. Leadership Chair in Genetic Medicine.
Learn MoreHave a look at the latest breakthroughs in Parkinson disease research; new genes, pathways, models, and diagnostic tools.
Parkinson disease is a complex, multifactorial neurodegenerative disease. Although a heritable basis was originally thought unlikely, recent studies have implicated several genes in its pathogenesis, and molecular findings now allow accurate diagnosis and challenge past criteria for defining Parkinson disease. Most importantly, genetic insights provide the rationale for new strategies for prevention or therapy, and have led to animal models of disease in which these strategies can be tested. Neuroprotective therapies can now be designed to slow or halt disease progression in affected subjects and asymptomatic carriers. << Learn More >>